Unusual Voltage-Gated Sodium and Potassium Channelopathies Related to Epilepsy

키워드

참고문헌 (66)

1. Macnee M, "Data-driven historical characterization of epilepsyassociated genes", Eur J Paediatr Neurol, 42, pp.82~87 (2023)
2. Menezes LFS, "Epilepsy-related voltage-gated sodium channelopathies : a review", Front Pharmacol, 11, pp.1276~ (2020)
3. Maljevic S, "Potassium channels : a review of broadening therapeutic possibilities for neurological diseases", J Neurol, 260, pp.2201~2211 (2013)
4. Kim SH, "Probandonly clinical exome sequencing for neurodevelopmental disabilities", Pediatr Neurol, 99, pp.47~54 (2019)
5. Rim JH, "Efficient strategy for the molecular diagnosis of intractable early-onset epilepsy using targeted gene sequencing", BMC Med Genomics, 11, pp.6~ (2018)
6. Kim SH, "Common genes and recurrent causative variants in 957 Asian patients with pediatric epilepsy", Epilepsia, 65, pp.766~778 (2024)
7. Richards S, "Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)
8. Omasits U, "Protter : interactive protein feature visualization and integration with experimental proteomic data", Bioinformatics, 30, pp.884~886 (2014)
9. Fisher RS, "ILAE official report : a practical clinical definition of epilepsy", Epilepsia, 55, pp.475~482 (2014)
10. Wirrell EC, "Methodology for classification and definition of epilepsy syndromes with list of syndromes : report of the ILAE task force on nosology and definitions", Epilepsia, 63, pp.1333~1348 (2022)
11. Raga S, "Developmental and epileptic encephalopathies : recognition and approaches to care", Epileptic Disord, 23, pp.40~52 (2021)
12. Brodie MJ, "Patterns of treatment response in newly diagnosed epilepsy", Neurology, 78, pp.1548~1554 (2012)
13. Zaman T, "SCN3A-related neurodevelopmental disorder : a spectrum of epilepsy and brain malformation", Ann Neurol, 88, pp.348~362 (2020)
14. Vicart S, "New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis", Neurology, 63, pp.2120~2127 (2004)
15. Ko A, "Targeted gene panel and genotype-phenotype correlation in children with developmental and epileptic encephalopathy", Epilepsy Res, 141, pp.48~55 (2018)
16. Döring JH, "Refining genotypes and phenotypes in KCNA2-related neurological disorders", Int J Mol Sci, 22, pp.2824~ (2021)
17. Kim SH, "Analysis of trio test in neurodevelopmental disorders", Front Pediatr, 10, pp.1073083~ (2022)
18. Saitsu H, "De novo KCNB1 mutations in infantile epilepsy inhibit repetitive neuronal firing", Sci Rep, 5, pp.15199~ (2015)
19. Bar C, "Expanding the genetic and phenotypic relevance of KCNB1 variants in developmental and epileptic encephalopathies : 27 new patients and overview of the literature", Hum Mutat, 41, pp.69~80 (2020)
20. de Kovel CG, "Targeted sequencing of 351 candidate genes for epileptic encephalopathy in a large cohort of patients", Mol Genet Genomic Med, 4, pp.568~580 (2016)
21. Cameron JM, "Encephalopathies with KCNC1 variants : genotype-phenotype-functional correlations", Ann Clin Transl Neurol, 6, pp.1263~1272 (2019)
22. Holland KD, "Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy", Neurosci Lett, 433, pp.65~70 (2008)
23. Vanoye CG, "Novel SCN3A variants associated with focal epilepsy in children", Neurobiol Dis, 62, pp.313~322 (2014)
24. Inuzuka LM, "Neurodevelopmental disorder associated with de novo SCN3A pathogenic variants : two new cases and review of the literature", Brain Dev, 42, pp.211~216 (2020)
25. Zaman T, "Mutations in SCN3A cause early infantile epileptic encephalopathy", Ann Neurol, 83, pp.703~717 (2018)
26. Guerrini R, "Monogenic epilepsies : disease mechanisms, clinical phenotypes, and targeted therapies", Neurology, 97, pp.817~831 (2021)
27. Castro PA, "Antiseizure medication in early nervous system development. Ion channels and synaptic proteins as principal targets", Front Pharmacol, 13, pp.948412~ (2022)
28. Sait LG, "Cannabidiol interactions with voltage-gated sodium channels", Elife, 9, pp.e58593~ (2020)
29. Bergareche A, "SCN4A pore mutation pathogenetically contributes to autosomal dominant essential tremor and may increase susceptibility to epilepsy", Hum Mol Genet, 24, pp.7111~7120 (2015)
30. Cao L, "Normokalemic periodic paralysis with involuntary movements and generalized epilepsy associated with two novel mutations in SCN4A gene", Seizure, 24, pp.134~136 (2015)
31. Duan BC, "Alternating hemiplegia and paroxysmal torticollis caused by SCN4A mutation : a new phenotype?", Neurology, 93, pp.673~674 (2019)
32. Brodie MJ, "Antiepileptic drug therapy the story so far", Seizure, 19, pp.650~655 (2010)
33. Ben-Johny M, "Conservation of Ca2+", calmodulin regulation across Na and Ca2+channels, 2014, pp.157, 1657~1670
34. Verdura E, "Complete loss of KCNA1 activity causes neonatal epileptic encephalopathy and dyskinesia", J Med Genet, 57, pp.132~137 (2020)
35. Yuan H, "Two novel KCNA1 variants identified in two unrelated Chinese families affected by episodic ataxia type 1 and neurodevelopmental disorders", Mol Genet Genomic Med, 8, pp.e1434~ (2020)
36. Paulhus K, "Novel genetic variants expand the functional, molecular, and pathological diversity of KCNA1 channelopathy", Int J Mol Sci, 24, pp.8826~ (2023)
37. Lauxmann S, "Therapeutic potential of sodium channel blockers as a targeted therapy approach in KCNA1-associated episodic ataxia and a comprehensive review of the literature", Front Neurol, 12, pp.703970~ (2021)
38. Dinoi G, "Clinical and functional study of a de novo variant in the PVP motif of Kv1. 1 channel associated with epilepsy, developmental delay and ataxia", Int J Mol Sci, 23, pp.8079~ (2022)
39. Miceli F, "Distinct epilepsy phenotypes and response to drugs in KCNA1gain-and loss-of function variants", Epilepsia, 63, pp.e7~e14 (2022)
40. Simeone KA, "Ketogenic diet-mediated seizure reduction preserves CA1 cell numbers in epileptic Kcna1-null mice : an unbiased stereological assessment", Epilepsia, 62, pp.e123~e128 (2021)
41. Misonou H, "Kv2. 1 : a voltage-gated K+channel critical to dynamic control of neuronal excitability", Neurotoxicology, 26, pp.743~752 (2005)
42. Brew HM, "Seizures and reduced life span in mice lacking the potassium channel subunit Kv1. 2, but hypoexcitability and enlarged Kv1currents in auditory neurons", J Neurophysiol, 98, pp.1501~1525 (2007)
43. Syrbe S, "De novo loss-or gain-of-function mutations in KCNA2 cause epileptic encephalopathy", Nat Genet, 47, pp.393~399 (2015)
44. Masnada S, "Clinical spectrum and genotype-phenotype associations of KCNA2-related encephalopathies", Brain, 140, pp.2337~2354 (2017)
45. Corbett MA, "Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy", Neurology, 87, pp.1975~1984 (2016)
46. Niday Z, "Potassium channel gain of function in epilepsy : an unresolved paradox", Neuroscientist, 24, pp.368~380 (2018)
47. Du J, "Persistent sodium current blockers can suppress seizures caused by loss of low-threshold D-type potassium currents : predictions from an in silico study of Kv1 channel disorders", Epilepsia Open, 5, pp.86~96 (2020)
48. Xiong J, "Correlation analyses of clinical manifestations and variant effects in KCNB1-related neurodevelopmental disorder", Front Pediatr, 9, pp.755344~ (2022)
49. Bocksteins E, "Electrically silent Kv subunits : their molecular and functional characteristics", Physiology(Bethesda), 27, pp.73~84 (2012)
50. de Kovel CGF, "Neurodevelopmental disorders caused by de novo variants in KCNB1genotypes and phenotypes", JAMA Neurol, 74, pp.1228~1236 (2017)
51. Hu C, "Phenotypic spectrum and longterm outcome of children with genetic early-infantile-onset developmental and epileptic encephalopathy", Epileptic Disord, 24, pp.343~352 (2022)
52. Gataullina S, "Gene mutations in paediatric epilepsies cause NMDA-pathy, and phasic and tonic GABA-pathy", Dev Med Child Neurol, 61, pp.891~898 (2019)
53. Löscher W, "Basic pharmacology of valproate : a review after 35 years of clinical use for the treatment of epilepsy", CNS Drugs, 16, pp.669~694 (2002)
54. Kaczmarek LK, "Kv3 channels : enablers of rapid firing, neurotransmitter release, and neuronal endurance", Physiol Rev, 97, pp.1431~1468 (2017)
55. Weiser M, "The potassium channel subunit KV3. 1b is localized to somatic and axonal membranes of specific populations of CNS neurons", J Neurosci, 15, pp.4298~4314 (1995)
56. Zhang Y, "A KCNC1mutation in epilepsy of infancy with focal migrating seizures produces functional channels that fail to be regulated by PKC phosphorylation", J Neurophysiol, 126, pp.532~539 (2021)
57. Ambrosino P, "A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy : "precision medicine"approach with fluoxetine", Epilepsia, 64, pp.e148~e155 (2023)
58. Clatot J, "A KCNC1-related neurological disorder due to gain of Kv3. 1 function", Ann Clin Transl Neurol, 10, pp.111~117 (2023)
59. Lauber E, "Prenatal valproate exposure differentially affects parvalbumin-expressing neurons and related circuits in the cortex and striatum of mice", Front Mol Neurosci, 9, pp.150~ (2016)
60. Yekhlef L, "Selective activation of parvalbumin-or somatostatin-expressing interneurons triggers epileptic seizurelike activity in mouse medial entorhinal cortex", J Neurophysiol, 113, pp.1616~1630 (2015)
61. Du W, "Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder", Nat Genet, 37, pp.733~738 (2005)
62. Yuan P, "Structure of the human BK channel Ca2+-activation apparatus at 3. 0 Å resolution", Science, 329, pp.182~186 (2010)
63. Bailey CS, "KCNMA1-linked channelopathy", J Gen Physiol, 151, pp.1173~1189 (2019)
64. Tabarki B, "Homozygous KCNMA1 mutation as a cause of cerebellar atrophy, developmental delay and seizures", Hum Genet, 135, pp.1295~1298 (2016)
65. Liang L, "De novo loss-of-function KCNMA1 variants are associated with a new multiple malformation syndrome and a broad spectrum of developmental and neurological phenotypes", Hum Mol Genet, 28, pp.2937~2951 (2019)
66. Harper AA, "Verapamil block of large-conductance Ca-activated K channels in rat aortic myocytes", J Membr Biol, 179, pp.103~111 (2001)

관련 논문AI추천